Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer

Details for Australian Patent Application No. 2002257802 (hide)

Owner Novartis AG

Inventors Seaman, John J.

Agent Davies Collison Cave

Pub. Number AU-B-2002257802

PCT Pub. Number WO2002/087555

Priority 60/288,220 02.05.01 US

Filing date 30 April 2002

Wipo publication date 11 November 2002

Acceptance publication date 16 February 2006

International Classifications

A61K 31/00 (2006.01)

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002257802

16 February 2006 Application Accepted

  Published as AU-B-2002257802

15 June 2006 Standard Patent Sealed

20 December 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002257803-GAIN CONTROL OF A POWER AMPLIFIER

2002257801-2-(4-(2, 2-DIHALOCYCLOPROPYL)PHENOXY) -ALKANOIC ACIDS AND ESTERS THEREOF PRODUCTION PROCESS